Advancing Therapies for Patients

Find a clinical trial

Molecular Profiling

page image
shadow image

Text Size

minus image

plus image

plus image


Print image

Email a Friend

Molecular Profiling

Find a clinical trial

Molecular Diagnostics

Molecular profiling has emerged to play a pivotal role in personalised medicine, classifying tumours based on genetic profiles for the purposes of diagnosing and treating cancers, or predicting response to therapy. Innovative technologies, including next generation sequencing, can now be used clinically to identify an extensive panel of actionable and exploratory genetic alterations.

Molecular Profiling and Personalized Medicine

In the UK, Sarah Cannon Molecular Diagnostics molecular profiling laboratory develops novel technologies and assay menus and provides a clinical service to the private sector and the NHS, as well as a comprehensive research platform to the pharmaceutical industry.

Latest Videos

watch the latest videos.

Learn more


news from the industry.

Read more

hero1 image
Sarah Cannon Research UK NHS Ventures
University College London Hospitals